Isotretinoin and risk of inflammatory bowel disease: A french nationwide study

American Journal of Gastroenterology

Volumn 109, Issue 4, 2014, Pages 563-569

  Racine, Antoine ^a,b   Cuerq, Anne ^c   Bijon, Anne ^b   Ricordeau, Philippe ^c   Weill, Alain ^c   Allemand, Hubert ^c   Chosidow, Olivier ^d   Boutron Ruault, Marie Christine ^b   Carbonnel, Franck ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b INSERM   (France)

^c Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ACNE; ADULT; ARTICLE; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DATA BASE; FEMALE; FRANCE; HUMAN; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL HEALTH INSURANCE; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; RISK FACTOR; ULCERATIVE COLITIS;

ADULT; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DATABASES, FACTUAL; DERMATOLOGIC AGENTS; FEMALE; FRANCE; HUMANS; ISOTRETINOIN; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS;

EID: 84898013304     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.8     Document Type: Article

References (30)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-34.
2. Baumgart DC, Carding SR. inflammatory bowel disease: Cause and immunobiology. Lancet 2007; 369: 1627-40.
3. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474: 307-17.
4. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet 2012; 380: 1590-605.
5. Ord á s I, Eckmann L, Talamini M et al. Ulcerative colitis. Lancet 2012; 380: 1606-19.
6. Kronman MP, Zaoutis TE, Haynes K et al. Antibiotic exposure and IBD development among children: A population-based cohort study. Pediatrics 2012; 130: E794-803.
7. Ananthakrishnan AN, Higuchi LM, Huang ES et al. Aspirin, nonsteroidal anti-infl ammatory drug use, and risk for Crohn disease and ulcerative colitis: A cohort study. Ann Intern Med 2012; 156: 350-9.
8. Cornish JA, Tan E, Simillis C et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: A meta-Analysis. Am J Gastroenterol 2008; 103: 2394-400.
9. Khalili H, Higuchi LM, Ananthakrishnan AN et al. Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. Gastroenterology 2012; 143: 1199-206.
10. Reddy D, Siegel CA, Sands BE et al. Possible association between isotretinoin and inflammatory bowel disease. Am J Gastroenterol 2006; 101: 1569-73.
11. Crockett SD, Porter CQ, Martin CF et al. Isotretinoin use and the risk of inflammatory bowel disease: A case-control study. Am J Gastroenterol 2010; 105: 1986-93.
12. Bernstein CN, Nugent Z, Longobardi T et al. Isotretinoin is not associated with inflammatory bowel disease: A population-based case-control study. Am J Gastroenterol 2009; 104: 2774-8.
13. Alhusayen RO, Juurlink DN, Mamdani MM et al. Isotretinoin use and the risk of inflammatory bowel disease: A Population-Based Cohort Study. J Invest Dermatol 2013; 133: 907-12.
14. Etminan M, Bird ST, Delaney JA et al. Isotretinoin and risk for inflammatory bowel disease: A nested case-control study and meta-Analysis of published and unpublished data. JAMA Dermatol 2013; 149: 216-20.
15. Margolis DJ, Fanelli M, Hoff stad O et al. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. Am J Gastroenterol 2010; 105: 2610-6.
16. Tuppin P, de Roquefeuil L, Weill A et al. French national health insurance information system and the permanent benefi ciaries sample. Rev Epidemiol Sante Publique 2010; 58: 286-90.
17. Nerich V, Monnet E, Weill A et al. Fine-scale geographic variations of inflammatory bowel disease in France: Correlation with socioeconomic and house equipment variables. Inflamm Bowel Dis 2010; 16: 813-21.
18. Nerich V, Jantchou P, Boutron-Ruault M-C et al. Low exposure to sunlight is a risk factor for Crohn's disease. Aliment Pharmacol 2011; 33: 940-5.
19. Firooz A, Sarhangnejad R, Davoudi SM et al. Acne and smoking: Is there a relationship?. BMC Dermatol 2005; 5: 2.
20. Molodecky NA, Soon IS, Rabi DM et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54. e42; quiz e30.
21. Chouraki V, Savoye G, Dauchet L et al. The changing pattern of Crohn's disease incidence in northern France: A continuing increase in the 10-To 19-year-old age bracket (1988-2007). Aliment Pharmacol 2011; 33: 1133-42.
22. Beaugerie L, Brousse N, Bouvier AM et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: A prospective observational cohort study. Lancet 2009; 374: 1617-25.
23. Jones DT, Osterman MT, Bewtra M et al. Passive smoking and inflammatory bowel disease: A meta-Analysis. Am J Gastroenterol 2008; 103: 2382-93.
24. Cosnes J. What is the link between the use of tobacco and IBD?. inflamm Bowel Dis 2008; 14 (Suppl 2): S14-5.
25. Cosnes J. Smoking, physical activity, nutrition and lifestyle: Environmental factors and their impact on IBD. Dig Dis 2010; 28: 411-7.
26. Capitanio B, Sinagra JL, Ottaviani M et al. Acne and smoking. Dermatoendocrinol 2009; 1: 129-35.
27. Rombouts S, Nijsten T, Lambert J. Cigarette smoking and acne in adolescents: Results from a cross-sectional study. J Eur Acad Dermatol Venereol 2007; 21: 326-33.
28. Mucida D, Park Y, Cheroutre H. From the diet to the nucleus: Vitamin A and TGF-beta join efforts at the mucosal interface of the intestine. Semin Immunol 2009; 21: 14-21.
29. Mora JR, Iwata M, Eksteen B et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006; 314: 1157-60.
30. Kang SG, Wang C, Matsumoto S et al. High and low vitamin A therapies induce distinct FoxP3+ T-cell subsets and effectively control intestinal inflammation. Gastroenterology 2009; 137: 1391-402. e1-6.